1. Xu, Ting, Zhang, Zhe, Chen, Hongqiang, Liu, Wenbin, Yao, Chunyan. 2022. Carboxypeptidase N2 as a Novel Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma. In Frontiers in oncology, 12, 843325. doi:10.3389/fonc.2022.843325. https://pubmed.ncbi.nlm.nih.gov/35686102/
2. Li, Jiao, Wang, Fei, Li, Zhen, Chai, Guoliang, Hao, Junwei. 2024. Integrative multi-omics analysis identifies genetically supported druggable targets and immune cell specificity for myasthenia gravis. In Journal of translational medicine, 22, 302. doi:10.1186/s12967-024-04994-2. https://pubmed.ncbi.nlm.nih.gov/38521921/
3. Iżykowska, Katarzyna, Przybylski, Grzegorz K, Gand, Claudia, Tensen, Cornelis P, Schmidt, Christian A. . Genetic rearrangements result in altered gene expression and novel fusion transcripts in Sézary syndrome. In Oncotarget, 8, 39627-39639. doi:10.18632/oncotarget.17383. https://pubmed.ncbi.nlm.nih.gov/28489605/
4. Matthews, Kirstin W, Mueller-Ortiz, Stacey L, Wetsel, Rick A. . Carboxypeptidase N: a pleiotropic regulator of inflammation. In Molecular immunology, 40, 785-93. doi:. https://pubmed.ncbi.nlm.nih.gov/14687935/
5. Nogueira, Valeria C, de Oliveira, Valzimeire do N, Guedes, Maria I F, de O M Moreira, Ana C, de A Moreira, Renato. 2022. UPLC-HDMSE to discover serum biomarkers in adults with type 1 diabetes. In International journal of biological macromolecules, 221, 1161-1170. doi:10.1016/j.ijbiomac.2022.09.085. https://pubmed.ncbi.nlm.nih.gov/36115450/
智鼠故事 
